[VRDN] YoY Annual Result on 31-Dec-2018 [#FY]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
14-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#FY]
Profit Trend
YoY- -23.35%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Annual Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 2,963 1,050 4,461 8,386 4,003 3,337 2,538 2.61%
PBT -79,413 -110,715 -41,873 -32,703 -26,512 -12,674 -11,328 38.30%
Tax 3 269 547 1,254 95 95 0 -
NP -79,416 -110,984 -42,420 -32,703 -26,512 -12,674 -11,328 38.30%
Tax Rate - - - - - - - -
Total Cost 82,379 112,034 46,881 41,089 30,515 16,011 13,866 34.54%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -2,680.26 -10,569.90 -950.91 -389.97 -662.30 -379.80 -446.34 34.78%
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -6.66 -31.20 -20.31 -16.57 -20.66 -17.57 -21.00 -17.40%
EPS Diluted -6.66 -31.20 -20.31 -16.57 -20.66 -17.57 -21.00 -17.40%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.